InsiderFlow

Matthew B. Klein

PTCT

Matthew B. Klein serves as director, officer: CHIEF EXECUTIVE OFFICER at PTC Therapeutics, Inc. (PTCT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$1.84M

Net Position

Net Seller

$1.84M

Companies Traded

1

PTCT

Active Period

Jan 2026 – Feb 2026

4 total trades

Most Recent

Sell PTCT

Feb 20, 2026 · $511.3K

Matthew B. Klein's Insider Trading at PTC Therapeutics, Inc. (PTCT)

Buys

0 · $0.00

Sells

4 · $1.84M

Total Shares Bought

0

Total Shares Sold

25,421

PTCT Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Feb 20, 2026Sell7,371$69.36$511.3K387,082
Feb 18, 2026Sell7,371$69.36$511.3K0
Jan 12, 2026Sell2,514$76.45$192.2K394,453
Jan 8, 2026Sell8,165$77.15$629.9K399,983